Difference between revisions of "MRE Biomarker Ctte"
Jump to navigation
Jump to search
| Line 16: | Line 16: | ||
==MRE Profile Development== | ==MRE Profile Development== | ||
| + | [[Media:Draft-MRE-QIBAProfile-2017-07-28.pdf|'''MRE Profile, Draft: July 28, 2017''']] | ||
[[Media:Draft-MRE-QIBAProfile-2017-07-06.pdf|'''MRE Profile, Initial Draft: July 6, 2017''']] | [[Media:Draft-MRE-QIBAProfile-2017-07-06.pdf|'''MRE Profile, Initial Draft: July 6, 2017''']] | ||
| − | |||
==Working Documents== | ==Working Documents== | ||
Revision as of 15:04, 31 July 2017
- Co-chairs: Richard L. Ehman, MD; Patricia Cole, PhD, MD
- Secretary: Susan Weinmann
- Roster
Project Snapshot
The MRE Biomarker Committee seeks to develop a quantitative Profile for MRE.
MRE Profile to be data-driven:
- focusing on the characterization of bias and precision in MRE measurement targets for achieving these measurements
- focusing on issues important to specific reproducibility
Meetings/Call Summaries
MRE Profile Development
MRE Profile, Draft: July 28, 2017 MRE Profile, Initial Draft: July 6, 2017